|
HY-141510-10mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-100mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-25mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-5mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-50mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-D0165-1g
|
MedChemexpress LLC
|
Naphthoresorcinol [CAS 132-86-5]
|
|
|
|
|
HY-126425-2mg
|
MedChemexpress LLC
|
NCGC00262650 [CAS 344359-25-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-N1449-1mg
|
MedChemexpress LLC
|
Neonuezhenide [CAS 96382-91-1]
|
|
|
|
|
HY-N1449-10mg
|
MedChemexpress LLC
|
Neonuezhenide [CAS 96382-91-1]
|
|
|
|
|
HY-N1449-5mg
|
MedChemexpress LLC
|
Neonuezhenide [CAS 96382-91-1]
|
|
|
|
|
HY-D0166A-5g
|
MedChemexpress LLC
|
Neutral Red (IND) [CAS 553-24-2]
|
|
|
|
|
HY-D0166-500mg
|
MedChemexpress LLC
|
Neutral Red [CAS 553-24-2]
|
|
|
|
|
HY-D0166-1mL
|
MedChemexpress LLC
|
Neutral Red [CAS 553-24-2] (10mM in DMSO)
|
|
|
|
|
HY-D0718-10mg
|
MedChemexpress LLC
|
Nile Red [CAS 7385-67-3]
|
|
|
|
|
HY-D0718-100mg
|
MedChemexpress LLC
|
Nile Red [CAS 7385-67-3]
|
|
|
|
|
HY-D0718-5mg
|
MedChemexpress LLC
|
Nile Red [CAS 7385-67-3]
|
|
|
|
|
HY-D0718-50mg
|
MedChemexpress LLC
|
Nile Red [CAS 7385-67-3]
|
|
|
|
|
HY-D0718-500mg
|
MedChemexpress LLC
|
Nile Red [CAS 7385-67-3]
|
|
|
|
|
HY-D0718-1mL
|
MedChemexpress LLC
|
Nile Red [CAS 7385-67-3] (10mM in DMSO)
|
|
|
|
|
HY-108913-1mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-108913-10mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-108913-100mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-108913-25mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-108913-5mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-108913-50mg
|
MedChemexpress LLC
|
Nitrocefin [CAS 41906-86-9]
|
|
COVID-19-immunoregulation
|
|
